期刊
BRITISH JOURNAL OF CANCER
卷 104, 期 4, 页码 554-558出版社
SPRINGERNATURE
DOI: 10.1038/sj.bjc.6606095
关键词
PML-RAR alpha; RXR; PU.I (SPII); epigenome
类别
资金
- European Union [LSHC-CT-2005-518417]
- Dutch Cancer Foundation [KWF KUN 2009-4527]
- Higher Education Commission of Pakistan
PML-RAR (retinoic acid receptor) a is the hallmark protein of acute promyelocytic leukaemia, a highly malignant subtype of acute myeloid leukaemia that accounts for approximately 10% of all AML cases. Recently, several studies have been set out to obtain a comprehensive genome-wide view of the molecular actions of this chimeric protein. In this review, we highlight the new insights that arose from these studies, in particular focussing on newly identified PML-RAR alpha target genes, its interplay with RXR and deregulation of epigenetic modifications. British Journal of Cancer (2011) 104, 554-558. doi:10.1038/sj.bjc.6606095 www.bjcancer.com Published online 18 January 2011 (C) 2011 Cancer Research UK
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据